Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
age associated memory impairment
aggression
agitation
algorithm
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early symptoms
Alzheimer's disease, patient awareness of
Alzheimer's disease, preclinical
Alzheimer's disease, prognosis of
Alzheimer's disease, risk factors in
Alzheimer's disease, telling patient diagnosis of
Alzheimer's disease, treatment of
amyloid beta protein
anosognosia
anticholinesterase
anticoagulant, treatment
antidepressant
antiphospholipid antibodies
anxiety
atypical
behavior
behavior, combative
behavioral disorder
biologic markers
carbamazepine
caregiver
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, venography
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
children
complications
controversies in neurology
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, diagnostic evaluation of
dementia, driving with
dementia, early detection
dementia, preexisting in stroke patient
dementia, screening for
dementia, treatment of
donepezil
driving
driving restrictions
driving test
dural sinus thrombosis
dying
efficacy
endovascular therapy
epidemiology of neurology
ethics in neurology
evidence-based research
exercise
Factor V Leiden
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
gadolinium
galantamine
headache
hydrocephalus
incidence
intellectual deficit
intracranial pressure, increased
level of consciousness, decreased
medical-legal aspects of neurology
memory
memory, impairment of
memory, impairment of, subjective
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
Mini Mental Status Examination
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, venography
neuroleptic
neuroleptic, atypical
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic examination, focal
neurologic symptoms
olanzapine
old age, driving and
old age, neurology of
oral contraceptives
patient information and support
pitfalls
practice guidelines
preclinical
pregnancy, neurologic complications in
prethrombotic state
prognosis
protein C deficiency
protein S deficiency
psychological testing
psychosis
psychotic behavior
quetiapine
review article
risk factors
risk factors, modification
risperidone
rivastigmine
safety
seizure
selective serotonin reuptake inhibitors
suicide
tissue plasminogen activator, intravenous
treatment of neurologic disorder
white matter disease
workup
Showing articles 0 to 50 of 1454 Next >>

Practice Guide Update Summary: Mild Cognitive Impairment
Neurol 90:126-135, Petersen, R.C.,et al, 2018

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011

The Older Adult Driver with Cognitive Impairment: "Its a Very Frustrating Life"
JAMA 303:1632-1641, 1642, 1660, Carr,D.B. &Ott,B.R., 2010

CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009

A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimers Disease
NEJM 355:1525-1538,1604, Schneider,L.S.,et al, 2006

Unawareness of Cognitive Deficit (Cognitive Anosognosia) in Probable AD and Control Subjects
Neurol 64:693-699, Barrett, A.M., et al, 2005

Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005

Cholinesterase Inhibitors for Patients with Alzheimers Disease: Systematic Review of Randomised Clinical Trials
BMJ 331:321-323, Kaduszkiewicz,H.,et al, 2005

End-of-Life Care and the Effects of Bereavement on Family Caregivers of Persons with Dementia
NEJM 349:1936-1942,1891, Schulz,R.,et al, 2003

Early Detection of Dementia: Mild Cognitive Impairment (an Evidence-based Review)
Neurol 56:1133-1142, 1131, Petersen,R.C.,et al, 2001

Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001

Telling Patients They Have Alzheimer's Disease
BMJ 314:321-322, 375-3761997., Rice,K.,et al, 1997

Preexisting Dementia in Stroke Patients, Baseline Frequency, Associated Factors, & Outcome
Stroke 28:2429-2436, Henon,H.,et al, 1997

Subjective Memory Complaints May Announce Dementia
Neurol 46:121-125, Schmand,B.,et al, 1996

Family Members'Attitudes Toward Telling the Patient with Alzheimer's Disease Their Diagnosis
BMJ 313:529-530, Maguire,C.P.,et al, 1996

Should Patients with Alzheimer's Disease be Told Their Diagnosis
NEJM 326:947-951, Drickamer,M.A.&Lachs,M.S., 1992

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025

Revised Criteria for Diagnosis and Staging of Alzheimers Disease: Alzheimers Association Workgroup
Alzheimers Dement 20:5143-5169, Jack,Jr.,C.R.,et al, 2024

Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024

Alzheimers Disease Biomarkers - Timing is Everything
NEJM 390:761-763, Mayeux,R., 2024

Repurposing Erectile Dysfunction Medication for Alzheimer Disease Prevention
Neurol 102:e209180, Yasara,S., & Nidadavolu,L., 2024

Evolving Role of Imaging in Acute Ischemic Stroke Care
Stroke 55:765-768, Ospel,J.M., & Boulouis,G., 2024

Cavernous Maliformations of the Central Nervous System
NEJM 390:1022-1028, Smith,E.R., 2024

Lecanemab for Alzheimer Disease, Is It Worth It?
Neurol 102:e209265, Nelson,S.E. & Lopez,O.L., 2024

Association of Acute Incidental Cerebral Microinfarcts with Subsequent Ischemic Stroke in Patients wth Cancer
Neurol 103: e209555, Naftali,J.,et al, 2024

Angioedema Following Tenecteplase for Acute Ischemic Stroke
Stroke 55:e242-e244, Dellabella,A.,et al, 2024

Angioedema After Use of Recombinant Tissue-Type Plasminogen Activators in Stroke
Stroke 55:2193-2197, Hutten,E., 2024

Surgical Management for Primary Intracerebral Hemorrhage
Neurol 103::e209714, Morris,N.A.,et al, 2024

Tau Positron Emission Tomography for Predicting Dementia in Individuals with Mild Cognitive Impairment
JAMA Neurol 81:845-856, Groot,C.,et al, 2024

Risk of Dementia After Initiation of Sodium-Glucose Cotransporter-2 Inhibitors Versus Dipeptidyl Peptidase-4 Inhibitors in Adults Aged 40-69 years with type 2 Diabetes:Population Based Cohort Study
BMJ doi:10.1136/BMJ-2024-07945, Shin,A., et al, 2024

SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
Neurol 103:e209805, Kim,H.K.,et al, 2024

Diagnosis of Incident Cancer After Cryptogenic Stroke
Neurol 103:e210027, Navi,B.B.,et al, 2024

How Patients Are Using AI
BMJ 387:q2393, Stokel-Walker,C., 2024

Amyloid-Related Imaging Abnormalities:An Update
AJR 220:562-575, Roytman,M.,et al, 2023

Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023

Clinicopathologic Conference, Paraneoplastic Vasculitis of the Central Nervous System
NEJM 388:747-757, Case 6-2023, 2023

Improved Prospects for Thrombectomy in Large Ischemic Stroke
NEJM 388:1326-1328,1259,1272, Fayad,P., 2023

Incidental Findings from 16,400 Brain MRI Examinations of Research Volunteers
AJNR 44:417-423, Rowley,P.A.,et al, 2023

Changing Trends in Demographics, Risk Factors, and Clinical Features of Patients with Infective Endocarditis-Related Stroke, 2005-2015
Neurol 100:e1555-e1564, Ridha,M.,et al, 2023

Cognitive and Clinical Characteristics of Patients with Limbic-Predominant Age-Related TDP-43 Encephalopathy
Neurol 100:e2027-e2035, Pagnotti,R.M.B.,et al, 2023

Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023

Toward Gerineuropalliative Care for Patients with Dementia
NEJM 389:775-778, Harrison,K.L.,et al, 2023

Thrombectomy for Acute Ischaemic Stroke Without Advanced Imaging
Lancet 402:1724-1725, Kippel,D.W.J. & Roozenbeek, B, 2023

Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Stroke 54:2981-2989, Yoo,J.,et al, 2023

Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment
Neurol 101:1079-1080, Bonami,S.,et al, 2023

Brexpiprazole for the Treatment of Agitation and Aggression in Alzheimers Disease
JAMA Neurol 80:1272-1273, Ballard,C., 2023

Thrombectomy for Anterior Circulation Stroke Beyond 6 h from Time Last Known Well (AURORA): A Systematic Review and Individual Patient Data Meta-Analysis
Lancet 399:249-258, Jovin, T.G.,et al, 2022



Showing articles 0 to 50 of 1454 Next >>